At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 76 enrolled
Drug / intervention
carbetocin 100 µg +2 moredrug
Likely dose
carbetocin 100 µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hemodynamic Effects of Carbetocin 100 µg, Oxytocin 5 U or Placebo After Cesarean Delivery Under Spinal Anesthesia in Healthy Pregnant Women.
In Brief
A Phase 4 clinical trial evaluating carbetocin 100 µg, oxytocin 5 u, and 1 other intervention for Effects of; Anesthesia, in Pregnancy. Completed, enrolled 76 participants across 2 sites.
Detailed Summary
A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEffects of; Anesthesia, in Pregnancy
CountriesNorway
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2009
Enrollment StartNov 2009
Primary CompletionAug 2011
Study CompletionOct 2011
TodayJul 2026
First PostedSep 16, 2009
Enrollment StartNov 1, 2009
Primary CompletionAug 1, 2011
Study CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.8 years ago
Interventions
carbetocin 100 µgdrug
Hemodynamic effect of
oxytocin 5 udrug
Hemodynamic effect of
placebo (NaCl)drug
Hemodynamic effect of